ArticleTheranostics2024

IL4 receptor targeting enables nab-paclitaxel to enhance reprogramming of M2-type macrophages into M1-like phenotype via ROS-HMGB1-TLR4 axis and inhibition of tumor growth and metastasis.

Sri Murugan Poongkavithai Vadevoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.